Shining a Light on the Sunshine Act and Transparency Requirements: Rules of the Road in Europe
France requires pharmaceutical and medical device companies to publicly disclose their agreements with a broad range of healthcare beneficiaries, along with the payments and benefits they provide — no matter where the company is headquartered. In the second episode of our “Shining a Light on the Sunshine Act and Transparency Requirements” series, Eveline Van Keymeulen, Global Vice Chair of Latham’s Healthcare & Life Sciences Practice, and Washington, D.C. counsel Nicole Liffrig Molife walk through the French transparency rules, including who must report, the wide range of healthcare beneficiaries covered, which agreements, benefits, and payments must be disclosed, and key reporting deadlines. They then take a quick tour of transparency requirements elsewhere in Europe, including the UK.
Listen here or subscribe via Apple Podcasts, Spotify, or anywhere else you listen to podcasts.